TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Intuitive Eating Scale-2
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pNGAL concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cut off value for perfusion index (PI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Emergent adverse events (AEs) and serious AEs (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of reported clinically significant changes from baseline in 12-lead electrocardiograms (ECGs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinically significant changes in vital signs, systolic and diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum CRH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Live-birth
Endpoint domain: Mortality/survival
Primary endpoint: Attitudes to Disclosure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: User discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ability to stay in place
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Content validity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement of respiratory signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Malignancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Utility
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in salivary estriol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Positive margins of invasive component
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Occurrence of a renal complication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: oxygen uptake (VO2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the serum concentration time curve to the infinite (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal Elimination half-life (t1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HF-related rehospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: rehospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with hospitalisation for unstable angina
Endpoint domain: Adverse events/effects
Primary endpoint: One leg stance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical cure at day 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge level of urinary catheter care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sonographic thigh adjustment ratio (STAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in pain (analgesics usage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in sensory change (monofilaments)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maintenance of physical condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pharmacological target attainment (Cmax ≥60 mg/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Short IBD Questionnaire (SIBDQ) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prediction of transient or persistent AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Parastomal hernia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants with cerebral vasospasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Visual analogue Scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Timed Functional Arm and Shoulder Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Photosensitivity Index (PI) at 10 minutes post UV irradiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Photosensitivity Index (PI) at 1 hour post UV irradiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Photosensitivity Index (PI) at 24 hours post UV irradiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily duration of skin-to-skin during postnatal hospitalisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Continuation of skin-to-skin after discharge
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: DFG measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Multifidus muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of composite endpoint of DVT and PE
Endpoint domain: Mortality/survival
Primary endpoint: Multidimensional Fatigue Inventory (MFI)-20
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Seropositive rate of COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Fertility Quality of Life (FertiQoL) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: shoulder Isometric strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: shoulder function (CKCUEST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: shoulder function (UQYBT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: shoulder function (SSPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in symptoms on the Adult Self Report (ASR)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Clinician Global Impairment rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: participant intervention satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Comfort with intervention discussion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intervention helpfulness in medication decisions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cycle threshold (Ct) value of COVID-19 nucleic acid after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pupillary redilatation velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Final outcome of the decision-making process
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Peri-implant diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Total Radioactivity in Whole Blood and in Plasma: AUC[0-t]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Radioactivity in Whole Blood and in Plasma: Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Radioactivity in Whole Blood and in Plasma: t1/2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of oocytes retrieved per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of MII oocytes per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Fertilization rate per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of frozen embryos per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in ratings of communication quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prolonged survival time without above-knee amputation
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of device and/or treatment related serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Responder rate defined as a study participant that reports a Hyperhidrosis Severity Scale (HDSS) score of 1 or 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sputum smear conversion according to microscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sputum smear conversion by culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: adapted modified Toronto Clinical Neuropathy Score (amTCNS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quantitative sensory testing (QST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Erasmus Polyneuropathy Symptom Score (E-PSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of enrolling and recruiting patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical site compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Follow-up with patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Presence of laboratory pro-thrombotic phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Seropositive rate of neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of Health-related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of Relationship Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Perceived Acceptability, Appropriateness, and Feasibility
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Oxidative-reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-ʈ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal phase elimination half-life (ʈ½)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal phase elimination rate (λZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of FFNP PET/MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of FFNP PET/MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of salivary cystatin S protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completing all study sessions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Evaluate Participant Satisfaction With the AMAZE™ App
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Emergency Room Visits, Urgent Care Center Visits, or Hospitalization Avoidance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient Satisfaction Questionnaire-18 Subscale Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients with new monogenic cardiovascular disease finding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall health profile
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arm Shoulder and Hand Problems Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Nordic Musculoskeletal Survey
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain control
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Problem Gambling Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Gambling Withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from serum serotonin/dopamine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint Space Narrowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Early diagnosis rate of HCC patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of glaucoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Eye outcomes
Primary endpoint: Change in frequency of bruxism episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in duration of bruxism episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean fold increase of neutralizing antibody against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of adverse reactions and the percentage of subjects with ≥ Grade 3 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Montgomery-asberg Depression Rating Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety measured as drug or device related SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: clinical outcome through participant clinical examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of obturation assessed by periapical intra oral radiographic technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed plasma drug concentration during a dosing interval (Cmax) of rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve from time zero to the time of the last observed/measured nonzero concentration (AUC0-last) of rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to Emergence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of responders in CASE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite success on CEA and PSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Canadian Occupational Performance Measure (MCRO)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficiency of vaginal examination interpretation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The total effectiveness rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in participant perceptions of well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Geographical mismatch
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hormonal factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Metabolic factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: rate of objective response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Suicide rates
Endpoint domain: Mortality/survival
Primary endpoint: Distal bone wall defect (DBWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross motor function measure-88 (GMFM-88)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral Palsy Quality of Life Questionnaire (CP QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Presence or absence of brain metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Primary tumor size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of participants with abnormal laboratory tests results and abnormal physical exam findings
Endpoint domain: Adverse events/effects
Primary endpoint: Remote plaque volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total Duration of Appropriate Treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Detection of tertiary lymphoid structure (TLS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Heart Rate Variability pNN50 at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in levels of DNA strand breaks in peripheral blood mononuclear cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Physical Activity (Step Count)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Lower Extremity Function (Balance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Lower Extremity Function (Gait Speed)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Lower Extremity Function (Chair Rise)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Exercise Capacity (Peak Oxygen Consumption)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in frailty status G8 status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in frailty status GFI status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HER3 Expression Prevalence Estimate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of OLGA III-IV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Irritability severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hypertension measured by patient activity workbook using emoji stickers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypertension measured by METUX Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Participants' experience score on METUX scales
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hypertension Medication Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Normoglycemia Achievement Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Confrontation Naming Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Testing Compliance to Verbalized Commands
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Testing for Finger Tapping Inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of life (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life Short Form 36 Health Survey Questionnaire (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of POD at one day after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of POD at three months after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in lip roughness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in lip wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Visual assessment of the lip
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Production of replication competent lentiviruses (RCL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Development of anti-drug antibodies (ADA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Depression
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in self-reported health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in the perception of caregiving effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Respiratory Tract Infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Relative cerebral blood flow (RCBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes